» Articles » PMID: 26152792

Identification of Toxoplasma Gondii Protein Fractions Induce Immune Response Against Melanoma in Mice

Overview
Journal APMIS
Date 2015 Jul 9
PMID 26152792
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Dendritic cells (DCs) play a crucial role in the initiation of adaptive immune responses against tumor cells. We recently found that protein components of Toxoplasma gondii (T. gondii) could mature DCs efficiently. Therefore, in this study, we aimed to find the most effective protein components of T. gondii which are able to mature DCs and consequently instruct immune responses in tumor-bearing mice. Soluble tachyzoite antigens (STAgs) were fractionated by ammonium sulfate precipitation and subsequently by anion-exchange HPLC. Immature DCs (iDCs) were treated by these protein fractions and were monitored for IL-12p70 and IL-10 production. Moreover, the capacity of mature DCs (mDCs) to induce lymphocyte proliferation was investigated. Ultimately, we analyzed the ability of mDCs in instructing immune responses in tumor-bearing mice. We found that ammonium sulfate fraction one (A1) matured-DCs produced higher IL-12 level and IL-12/IL-10 ratio; therefore, this fraction was selected for further fractionation by anion-exchange HPLC. The results showed that anion-exchange HPLC fraction 14 (C14) matured-DCs secrete higher levels of IL-12p70 and IL-12p70/IL-10 ratio. Survival of the mice matured by A1 fraction increased significantly compared to other groups. Moreover, SDS-PAGE electrophoresis showed that different obtained fractions have distinct proteins based on their size. These results demonstrate that two protein fractions of T. gondii are able to mature DCs more efficient.

Citing Articles

Association of Neuroblastoma (NB) SH-SY5Y Cells with Antibodies of Parasitic Origin (Anti- and Anti-).

Maravelez Acosta V, Garcia M, Patino Lopez G, Crisostomo Vazquez M, Franco Sandoval L, Eligio Garcia L Int J Mol Sci. 2025; 25(24.

PMID: 39769340 PMC: 11678856. DOI: 10.3390/ijms252413577.


Toxoplasma gondii-Derived Exosomes: A Potential Immunostimulant and Delivery System for Tumor Immunotherapy Superior to Toxoplasma gondii.

Zhao L, Sun Q, Wang C, Liu J, Yan X, Shao M Int J Nanomedicine. 2024; 19:12421-12438.

PMID: 39600411 PMC: 11590659. DOI: 10.2147/IJN.S483626.


Parasites revive hope for cancer therapy.

Eissa M, Salem A, El Skhawy N Eur J Med Res. 2024; 29(1):489.

PMID: 39367471 PMC: 11453045. DOI: 10.1186/s40001-024-02057-2.


A novel enemy of cancer: recent investigations into protozoan anti-tumor properties.

Zheng Z, Lu X, Zhou D, Deng X, Liu Q, Liu X Front Cell Infect Microbiol. 2024; 13:1325144.

PMID: 38274735 PMC: 10808745. DOI: 10.3389/fcimb.2023.1325144.


infection possibly reverses host immunosuppression to restrain tumor growth.

Chen J, Liao W, Peng H Front Cell Infect Microbiol. 2022; 12:959300.

PMID: 36118042 PMC: 9470863. DOI: 10.3389/fcimb.2022.959300.